Caplight Directory>Companies>EVerZom-preview>Everzom


EVerZom

EVerZom

Private
ParisN/Ahttps://everzom.com/

Last Round

Series A

Oct 14, 2025

Total Funding Raised

$18.19M

Momentum Score

75 /100

Company Overview

EVerZom is a biotechnology company that develops a biomanufacturing platform for exosome-based therapies for regenerative medicine applications.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EVerZom Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EVerZom Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AOct 14, 2025
GrantJun 17, 2025
GrantNov 18, 2021
SeedNov 30, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Nicolas Rousseau

Co-Founder - COO

Founding Team

Jeanne Volatron

CEO And Co-founder

Founding Team

EVerZom Investors

Notable investors and investment history

InvestorRounds
European Innovation CouncilGrant
European Innovation Council FundSeries A
Paris Business AngelsSeries A
Capital Grand EstSeries A
Sorbonne VentureSeries A
BpifranceGrant
Capital CellSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors grew 579% MoM, reaching 2.3K.

  • Nov 10, 2025

    Monthly visitors increased 253% MoM.

View all signals

EVerZom Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EVerZom Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EVerZom's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range20
Year Founded2019
Last FundingOct 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.